Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Stephen V. Liu is an Assistant Professor of Medicine and a practicing thoracic medical oncologist at the Lombardi Comprehensive Cancer Center at Georgetown University. He received his undergraduate degree at Johns Hopkins University and his medical degree at the University of Maryland. He then completed his internship and residency in Internal Medicine at the University of Pennsylvania and his fellowship training in Hematology and Oncology at the University of Southern California before joining the faculty of Georgetown University. Dr.

Targeted Therapies Forum Presented in English 2023 - Breakout Sessions 2
Our Targeted Therapies Forum online event includes a Q&A session where our amazing faculty answers questions from the audience. This is the second batch of videos of the Breakout Sessions.
Author
Stephen Liu, MD, GRACE Faculty
Image
Targeted Therapies Forum presented in English

This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics:

  • Safety and Toxicity of Selpercatinib Versus Pralsetinib
  • The Future of RET+ NSCLC Treatment
  • NTRK+ NSCLC: Treatment Options and Side Effects
  • NRG1 Fusions: Treatment Options

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.